Advertisement

Usefulness of Minimal Luminal Coronary Area Determined by Intravascular Ultrasound to Predict Functional Significance in Stable and Unstable Angina Pectoris

Published:January 16, 2012DOI:https://doi.org/10.1016/j.amjcard.2011.11.024
      Little is known about the intravascular ultrasound (IVUS) minimal lumen area (MLA) criteria and their accuracy in lesion subsets assorted according to vessel type, lesion location, vessel size, and clinical settings. We therefore assessed the accuracy of subgroup-specific cut-off values in predicting fractional flow reserve (FFR) <0.80. In total 692 consecutive patients with 784 coronary lesions were assessed by IVUS and FFR before intervention. All patients had ≥1 target vessel with a de novo lesion (30% to 90% diameter stenosis). For prediction of FFR <0.80 in the group overall, the best cut-off value of MLA was 2.4 mm2 (sensitivity 84% and specificity 63%). Overall diagnostic accuracy was only 69%. In the subgroup analysis, the MLA cutoff was 2.4 mm2 for the left anterior descending coronary artery, 1.6 mm2 for the left circumflex coronary artery, and 2.4 mm2 for the right coronary artery. By lesion location, the optimal cutoff was 2.6 mm2 for proximal, 2.3 mm2 for mid, and 1.9 mm2 for distal segments. Furthermore, the cutoffs were 3.2 mm2 in lesions with a larger RLD >3.5 mm and 1.9 mm2 in lesions with a smaller RLD <2.75 mm. Nevertheless, diagnostic accuracies of all subgroup-specific criteria were <80%. In conclusion, because IVUS-measured MLA is only 1 of many factors affecting coronary flow hemodynamics, even subgroup-specific criteria were inaccurate in identifying ischemia-inducible stenosis. In conclusion, direct functional assessment is therefore essential in guiding treatment strategies for coronary lesions.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shaw L.J.
        • Berman D.S.
        • Maron D.J.
        • Mancini G.B.
        • Hayes S.W.
        • Hartigan P.M.
        • Weintraub W.S.
        • O'Rourke R.A.
        • Dada M.
        • Spertus J.A.
        • Chaitman B.R.
        • Friedman J.
        • Slomka P.
        • Heller G.V.
        • Germano G.
        • Gosselin G.
        • Berger P.
        • Kostuk W.J.
        • Schwartz R.G.
        • Knudtson M.
        • Veledar E.
        • Bates E.R.
        • McCallister B.
        • Teo K.K.
        • Boden W.E.
        • COURAGE Investigators
        Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
        Circulation. 2008; 117: 1283-1291
        • Davies R.F.
        • Goldberg A.D.
        • Forman S.
        • Knatterud G.L.
        • Geller N.
        • Sopko G.
        • Pratt C.
        • Deanfield J.
        • Conti C.R.
        Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
        Circulation. 1997; 95: 2037-2043
        • Erne P.
        • Schoenenberger A.W.
        • Burckhardt D.
        • Zuber M.
        • Kiowski W.
        • Buser P.T.
        • Dubach P.
        • Resink T.J.
        • Pfisterer M.
        Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
        JAMA. 2007; 297: 1985-1991
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.M.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini G.B.
        • Weintraub W.S.
        • COURAGE Trial Research Group
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Pijls N.H.
        • van Schaardenburgh P.
        • Manoharan G.
        • Boersma E.
        • Bech J.W.
        • van't Veer M.
        • Bär F.
        • Hoorntje J.
        • Koolen J.
        • Wijns W.
        • de Bruyne B.
        Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.
        J Am Coll Cardiol. 2007; 49: 2105-2111
        • Pijls N.H.
        • De Bruyne B.
        • Peels K.
        • Van Der Voort P.H.
        • Bonnier H.J.
        • Bartunek J.J.
        • Koolen J.J.
        Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses.
        N Engl J Med. 1996; 334: 1703-1708
        • De Bruyne B.
        • Pijls N.H.
        • Bartunek J.
        • Kulecki K.
        • Bech J.W.
        • De Winter H.
        • Van Crombrugge P.
        • Heyndrickx G.R.
        • Wijns W.
        Fractional flow reserve in patients with prior myocardial infarction.
        Circulation. 2001; 104: 157-162
        • Pijls N.H.
        • Van Gelder B.
        • Van der Voort P.
        • Peels K.
        • Bracke F.A.
        • Bonnier H.J.
        • el Gamal M.I.
        Fractional flow reserve.
        Circulation. 1995; 92: 3183-3193
        • Berger A.
        • Botman K.J.
        • MacCarthy P.A.
        • Wijns W.
        • Bartunek J.
        • Heyndrickx G.R.
        • Pijls N.H.
        • De Bruyne B.
        Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.
        J Am Coll Cardiol. 2005; 46: 438-442
        • Wongpraparut N.
        • Yalamanchili V.
        • Pasnoori V.
        • Satran A.
        • Chandra M.
        • Masden R.
        • Leesar M.A.
        Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention.
        Am J Cardiol. 2005; 96: 877-884
        • Tonino P.A.
        • De Bruyne B.
        • Pijls N.H.
        • Siebert U.
        • Ikeno F.
        • van't Veer M.
        • Klauss V.
        • Manoharan G.
        • Engstrøm T.
        • Oldroyd K.G.
        • Ver Lee P.N.
        • MacCarthy P.A.
        • Fearon W.F.
        • FAME Study Investigators
        Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
        N Engl J Med. 2009; 360: 213-224
        • Takagi A.
        • Tsurumi Y.
        • Ishii Y.
        • Suzuki K.
        • Kawana M.
        • Kasanuki H.
        Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve.
        Circulation. 1999; 100: 250-255
        • Nishioka T.
        • Amanullah A.M.
        • Luo H.
        • Berglund H.
        • Kim C.J.
        • Nagai T.
        • Hakamata N.
        • Katsushika S.
        • Uehata A.
        • Takase B.
        • Isojima K.
        • Berman D.S.
        • Siegel R.J.
        Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: comparison with stress myocardial perfusion imaging.
        J Am Coll Cardiol. 1999; 33: 1870-1878
        • Abizaid A.
        • Mintz G.S.
        • Pichard A.D.
        • Kent K.M.
        • Satler L.F.
        • Walsh C.L.
        • Popma J.J.
        • Leon M.B.
        Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty.
        Am J Cardiol. 1998; 82: 423-428
        • Briguori C.
        • Anzuini A.
        • Airoldi F.
        • Gimelli G.
        • Nishida T.
        • Adamian M.
        • Corvaja N.
        • Di Mario C.
        • Colombo A.
        Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve.
        Am J Cardiol. 2001; 87: 136-141
        • Kern M.J.
        Use and abuse of IVUS and FFR by Magni V et al. or why you shouldn't believe the saying, “if you want to treat, use IVUS. If you don't, use FFR”.
        Catheter Cardiovasc Interv. 2009; 74: 811-813
        • Magni V.
        • Chieffo A.
        • Colombo A.
        Evaluation of intermediate coronary stenosis with intravascular ultrasound and fractional flow reserve: Its use and abuse.
        Catheter Cardiovasc Interv. 2009; 73: 441-448
        • Lee C.H.
        • Tai B.C.
        • Soon C.Y.
        • Low A.F.
        • Poh K.K.
        • Yeo T.C.
        • Lim G.H.
        • Yip J.
        • Omar A.R.
        • Teo S.G.
        • Tan H.C.
        New set of intravascular ultrasound-derived anatomic criteria for defining functionally significant stenoses in small coronary arteries (results from Intravascular Ultrasound Diagnostic Evaluation of Atherosclerosis in Singapore [IDEAS] study).
        Am J Cardiol. 2010; 105: 1378-1384
        • Koo B.K.
        • Yang H.M.
        • Doh J.H.
        • Choe H.
        • Lee S.Y.
        • Yoon C.H.
        • Cho Y.K.
        • Nam C.W.
        • Hur S.H.
        • Lim H.S.
        • Yoon M.H.
        • Park K.W.
        • Na S.H.
        • Youn T.J.
        • Chung W.Y.
        • Park S.K.
        • Kim H.S.
        • Tahk S.J.
        Optimal intravascular ultrasound criteria and their accuracy for defining the functional significance of intermediate coronary stenoses of different locations.
        JACC Cardiovasc Interv. 2011; 4: 803-811
        • Kang S.J.
        • Lee J.Y.
        • Ahn J.M.
        • Mintz G.S.
        • Kim W.J.
        • Park D.W.
        • Yun S.C.
        • Lee S.W.
        • Kim Y.H.
        • Lee C.W.
        • Park S.W.
        • Park S.J.
        Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity.
        Circ Cardiovasc Interv. 2011; 4: 65-71
        • Nam C.W.
        • Yoon H.J.
        • Cho Y.K.
        • Park H.S.
        • Kim H.
        • Hur S.H.
        • Kim Y.N.
        • Chung I.S.
        • Koo B.K.
        • Tahk S.J.
        • Fearon W.F.
        • Kim K.B.
        Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided.
        JACC Cardiovasc Interv. 2010; 3: 812-817
        • Ryan T.J.
        • Faxon D.P.
        • Gunnar R.M.
        • Kennedy J.W.
        • King III, S.B.
        • Loop F.D.
        • Peterson K.L.
        • Reeves T.J.
        • Williams D.O.
        • Winters Jr, W.L.
        Guidelines for percutaneous transluminal coronary angioplasty.
        Circulation. 1988; 78: 486-502
        • Mintz G.S.
        • Nissen S.E.
        • Anderson W.D.
        • Bailey S.R.
        • Erbel R.
        • Fitzgerald P.J.
        • Pinto F.J.
        • Rosenfield K.
        • Siegel R.J.
        • Tuzcu E.M.
        • Yock P.G.
        American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS).
        J Am Coll Cardiol. 2001; 37: 1478-1492